Skip to main content
Log in

Experimental Evaluation of Chronic Toxicity of Amphamide – a New Semisynthetic Derivative of Amphotericin B

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

Amphotericin B (AmB) remains a drug of first choice for treatment of most severe mycoses despite significant toxicity and solubility problems. Screening of a series of new semisynthetic polyene macrolide derivatives identified AmB N-(2-aminoethyl)amide (amphamide) as having several competitive advantages over the parent polyene. Aprototype parenteral amphamide dosage form in which the active ingredient was highly soluble and stable during storage was developed. Chronic toxicity of the finished amphamide dosage form was studied in rabbits. The amphamide dosage form displayed dose-dependent reversible toxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. L. Scorzoni, A. C. A. de Paula e Silva, C. M. Marcos, et al., Front. Microbiol., 8, 36 (2017); doi: 10.3389/fmicb.2017. 00036.

  2. O. A. Omelchuk, A. N. Tevyashova, and A. E. Shchekotikhin, Russ. Chem. Rev., 87(12), 1206 – 1225 (2018); doi: https://doi.org/10.1070/RCR4841.

    Article  CAS  Google Scholar 

  3. M. N. Preobrazhenskaya, E. N. Olsufyeva, S. E. Solovieva, et al., J. Med. Chem., 52(1), 189 – 196 (2009); doi: https://doi.org/10.1021/jm800695k

    Article  CAS  PubMed  Google Scholar 

  4. M. N. Preobrazhenskaya, E. N. Olsufyeva, A. N. Tevyashova, et al., J. Antibiot., 63(2), 55 – 64 (2010); doi: https://doi.org/10.1038/ja.2009.118.

    Article  CAS  PubMed  Google Scholar 

  5. A. N. Tevyashova, E. N. Olsufyeva, S. E. Solovieva, et al., Antimicrob. Agents Chemother., 57(8), 3815 – 3822 (2013); doi: 10.1128/AAC.00270 – 13.

  6. A. N. Tevyashova, A. M. Korolev, A. S. Trenin, et al., J. Antibiot., 69(7), 549 – 560 (2016); doi: https://doi.org/10.1038/ja.2016.34.

    Article  CAS  PubMed  Google Scholar 

  7. S. S. Efimova, A. N. Tevyashova, E. N. Olsufyeva, et al., PLoS One, 12, No. 11, e0188573 (2017); doi: https://doi.org/10.1371/journal.pone.0188573.

  8. A. N. Tevyashova, A. E. Shchekotikhin, N. E. Grammatikova, et al., RU Pat. No. 2,688,658, May 22, 2019; Byull. Izobret., No. 15 (2019).

  9. A. N. Tevyashova, E. N. Bychkova, S. E. Solov'eva, e al., Khim.-farm. Zh., 53(10), 50 – 54 (2019); doi: 10.30906/0023-1134-2019-53-10-50-54.

  10. European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes, Council of Europe, ETS No. 123 (1986).

  11. A. N. Mironov (ed.), Handbook for Preclinical Drug Trials [in Russian], Vol. 1, Grif i K, Moscow (2012), pp. 13 – 24.

  12. E. J. Freireich, E. A. Gehan, D. P. Rall, et al., Cancer Chemother. Rep., 50(4), 219 – 244 (1966).

    CAS  PubMed  Google Scholar 

  13. C. Viscoli, C. Girmenia, A. Marinus, et al., Clin. Infect. Dis., 28(5), 1071 – 1079 (1999); doi: https://doi.org/10.1086/514731.

    Article  CAS  PubMed  Google Scholar 

  14. T. Massa, D. P. Sinha, J. D. Frantz, et al., Fundam. Appl. Toxicol., 5(4), 737 – 753 (1985); doi: https://doi.org/10.1093/toxsci /5.4.737.

  15. P. J. Danaher, M. K. Cao, G. M. Anstead, et al., J. Antimicrob. Chemother., 53(1), 115 – 117 (2004); doi:https://doi.org/10.1093/jac/dkg472.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. N. Tevyashova.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 53, No. 11, pp. 30 – 33, November, 2019.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pereverzeva, E.R., Treshchalin, M.I., Bychkova, E.N. et al. Experimental Evaluation of Chronic Toxicity of Amphamide – a New Semisynthetic Derivative of Amphotericin B. Pharm Chem J 53, 1018–1021 (2020). https://doi.org/10.1007/s11094-020-02116-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-020-02116-y

Keywords

Navigation